Coronavirus vaccine candidate maker Pfizer was expected to release early efficacy results for Phase 3 in mid-October, ahead of the presidential election. That’s no longer the case, as the first efficacy data isn’t >>
Pfizer News
We’re not getting a coronavirus vaccine before the election
The company making the only coronavirus vaccine with a theoretical chance of being approved before the US presidential election made it clear such a timeline is unfeasible. Pfizer CEO Albert Bourla said his >>
This promising coronavirus vaccine could be ready within 3 months
A second coronavirus vaccine trial has entered the final stage of testing, and the research could be finalized as soon as October. One of the BioNTech/Pfizer vaccine candidates that were studied in preclinical >>
This is fantastic news about one of the most promising coronavirus vaccines
The latest coronavirus vaccine development update comes from the US government, which inked a new deal for a promising vaccine made by BioNTech and Pfizer. The government pledged nearly $2 billion to secure >>
Another coronavirus vaccine candidate might be ready sooner than expected
Another potential coronavirus vaccine might be available this fall. Pfizer said the candidate it’s developing with BioNTech could be ready by October if everything goes well. There’s no guarantee that any of these >>
Another coronavirus vaccine is starting clinical trials in the US
German biopharmaceutical company BioNTech partnered with Pfizer on the development of an mRNA vaccine for the novel coronavirus. Their product reached the clinical phase trial stage, with Phase 1/2 testing already underway in >>
